MC 2131 5-Bromovinyl-2'-deoxyuridine, [2-14C]- |
|
(Brivudine, [2-14C]-) | |
|
|
Ethanol:water (1:1) solution, 100 μCi/ml | Please Inquire for Pricing |
> 50 mCi(1.85 GBq)/mmol | |
NextGen V-Vial - shipped on dry ice | |
M.W. 333.14 | |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. |
MT 963 5-(Bromovinyl) 2'-deoxyuridine, [2'-3H]- (Discontinued) |
|
(Brivudine, [2'-3H]-) | |
|
|
Ethanol:water (1:1) solution, 1 mCi/ml | |
> 1 Ci(37 GBq)/mmol | |
NextGen V-Vial | |
M.W. 333.1 | |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. |
MT 1738 5-(Bromovinyl) 2'-deoxyuridine, [5'-3H]- (Discontinued) |
|
(Brivudine, [5'-3H]-) | |
|
|
Ethanol:water (1:1) solution, 1 mCi/ml | |
> 1 Ci(37 GBq)/mmol | |
NextGen V-Vial - shipped on dry ice | |
M.W. 333.1 | |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. |